share_log

Ardelyx | 8-K: Current report

Ardelyx | 8-K:重大事件

美股sec公告 ·  01/08 00:00
Moomoo AI 已提取核心訊息
On January 8, 2024, Ardelyx, Inc. reported unaudited financial results for the fourth quarter and full year ended December 31, 2023. The company disclosed U.S. net product sales revenue of approximately $28 million for IBSRELA (tenapanor) in the fourth quarter, and around $80 million for the entire year. Additionally, Ardelyx announced unaudited U.S. net product sales revenue for XPHOZAH (tenapanor) of approximately $2.5 million for the same quarter. The preliminary report also included that the company had about $184 million in cash, cash equivalents, and short-term investments as of the year-end. These figures are subject to adjustments as they are part of the preparation for audited financial statements and may materially differ from the final amounts reported in the company's financial statements for the year.
On January 8, 2024, Ardelyx, Inc. reported unaudited financial results for the fourth quarter and full year ended December 31, 2023. The company disclosed U.S. net product sales revenue of approximately $28 million for IBSRELA (tenapanor) in the fourth quarter, and around $80 million for the entire year. Additionally, Ardelyx announced unaudited U.S. net product sales revenue for XPHOZAH (tenapanor) of approximately $2.5 million for the same quarter. The preliminary report also included that the company had about $184 million in cash, cash equivalents, and short-term investments as of the year-end. These figures are subject to adjustments as they are part of the preparation for audited financial statements and may materially differ from the final amounts reported in the company's financial statements for the year.
2024年1月8日,Ardelyx, Inc.公佈了截至2023年12月31日的第四季度和全年未經審計的財務業績。該公司披露,第四季度IBSRELA(tenapanor)在美國的淨產品銷售收入約爲2,800萬美元,全年約爲8000萬美元。此外,Ardelyx宣佈,同期XPHOZAH(tenapanor)未經審計的美國淨產品銷售收入約爲250萬美元。初步報告還包括,截至年底,該公司擁有約1.84億美元的現金、現金等價物和短期投資。這些數字可能會進行調整,因爲它們是經審計的財務報表準備工作的一部分,可能與公司當年財務報表中報告的最終金額存在重大差異。
2024年1月8日,Ardelyx, Inc.公佈了截至2023年12月31日的第四季度和全年未經審計的財務業績。該公司披露,第四季度IBSRELA(tenapanor)在美國的淨產品銷售收入約爲2,800萬美元,全年約爲8000萬美元。此外,Ardelyx宣佈,同期XPHOZAH(tenapanor)未經審計的美國淨產品銷售收入約爲250萬美元。初步報告還包括,截至年底,該公司擁有約1.84億美元的現金、現金等價物和短期投資。這些數字可能會進行調整,因爲它們是經審計的財務報表準備工作的一部分,可能與公司當年財務報表中報告的最終金額存在重大差異。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息